DE69711609D1 - Verfahren zum entfernen von unkonventionellen krankheitserregern aus proteinlösungen - Google Patents

Verfahren zum entfernen von unkonventionellen krankheitserregern aus proteinlösungen

Info

Publication number
DE69711609D1
DE69711609D1 DE69711609T DE69711609T DE69711609D1 DE 69711609 D1 DE69711609 D1 DE 69711609D1 DE 69711609 T DE69711609 T DE 69711609T DE 69711609 T DE69711609 T DE 69711609T DE 69711609 D1 DE69711609 D1 DE 69711609D1
Authority
DE
Germany
Prior art keywords
unconventional
diseases
protein solutions
present
aqueous protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69711609T
Other languages
English (en)
Other versions
DE69711609T2 (de
Inventor
Michel Grandgeorge
Rene Labatut
Jean-Marc Rouzioux
Jean-Louis Tayot
Jean-Luc Veron
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IMEDEX CHAPONOST
Sanofi Pasteur SA
Original Assignee
IMEDEX CHAPONOST
Aventis Pasteur SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9603549A external-priority patent/FR2746030B1/fr
Priority claimed from FR9608548A external-priority patent/FR2750887B1/fr
Application filed by IMEDEX CHAPONOST, Aventis Pasteur SA filed Critical IMEDEX CHAPONOST
Application granted granted Critical
Publication of DE69711609D1 publication Critical patent/DE69711609D1/de
Publication of DE69711609T2 publication Critical patent/DE69711609T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0017—Filtration
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/32—Bonded phase chromatography
    • B01D15/325—Reversed phase
    • B01D15/327—Reversed phase with hydrophobic interaction
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B01D15/363—Anion-exchange

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
DE69711609T 1996-03-15 1997-03-14 Verfahren zum entfernen von unkonventionellen krankheitserregern aus proteinlösungen Expired - Fee Related DE69711609T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9603549A FR2746030B1 (fr) 1996-03-15 1996-03-15 Procede pour eliminer les agents transmissibles non conventionnels (atnc) d'une solution d'albumine
FR9608548A FR2750887B1 (fr) 1996-07-09 1996-07-09 Procede d'elimination des agents transmissibles non conventionnels (atnc) d'une solution proteique
PCT/FR1997/000465 WO1997034642A1 (fr) 1996-03-15 1997-03-14 Procede pour eliminer les agents transmissibles non conventionnels d'une solution proteique

Publications (2)

Publication Number Publication Date
DE69711609D1 true DE69711609D1 (de) 2002-05-08
DE69711609T2 DE69711609T2 (de) 2002-11-28

Family

ID=26232601

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69711609T Expired - Fee Related DE69711609T2 (de) 1996-03-15 1997-03-14 Verfahren zum entfernen von unkonventionellen krankheitserregern aus proteinlösungen

Country Status (7)

Country Link
US (1) US6372510B1 (de)
EP (1) EP0888131B1 (de)
AT (1) ATE215387T1 (de)
AU (1) AU731770B2 (de)
DE (1) DE69711609T2 (de)
NZ (1) NZ332323A (de)
WO (1) WO1997034642A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0937735T3 (da) * 1998-02-11 2003-06-02 Zlb Bioplasma Ag Fremgangsmåde til fjernelse af kausalt agens/kausale agentia for overførbare spongiforme encephalopatier fra proteinopløsninger
JP6749590B2 (ja) * 2015-09-17 2020-09-02 国立大学法人 東京大学 酸化型及び還元型アルブミンの分析方法、酸化型及び還元型アルブミンの分析装置、及び酸化型及び還元型アルブミンの分析キット

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU605901B2 (en) 1987-09-11 1991-01-24 Ares Trading S.A. Purification process
FR2648048B1 (fr) * 1989-06-08 1994-06-03 Lille Transfusion Sanguine Procede de preparation de solutions d'albumine purifiee
AT408191B (de) * 1991-08-19 2001-09-25 Haemosan Erzeugung Pharmazeuti Verfahren zur inaktivierung von prionen
IT1260149B (it) 1992-04-17 1996-03-28 Fidia Spa Metodo per la preparazione e purificazione di miscele di fosfolipidi prive di contaminanti da virus non convenzionali
JP3351572B2 (ja) * 1992-10-05 2002-11-25 井上 聰一 イオンクロマトグラフィーによる分析体の分離・分析方法、イオンクロマトグラフィー用両荷電具備固定相及び多機能液体クロマトグラフィーによる分析体の分離・分析方法
JP3279362B2 (ja) * 1992-10-05 2002-04-30 井上 聰一 糖尿病判定方法及び糖尿病判定装置
WO1994009063A1 (en) * 1992-10-21 1994-04-28 Cornell Research Foundation, Inc. Pore-size selective modification of porous materials
GB9307523D0 (en) * 1993-04-13 1993-06-02 Mini Agriculture & Fisheries Detection of cns gases
FR2715405B1 (fr) * 1994-01-24 1996-04-05 Imedex Procédé pour l'élimination des prions dans des collagènes et collagènes ainsi obtenus.
DE4429558A1 (de) * 1994-08-19 1996-02-22 Sanorell Pharma Gmbh & Co Verfahren zur Herstellung von infektionsfreien pharmazeutischen Präparaten und/oder Nahrungsmitteln aus infektiösem Material

Also Published As

Publication number Publication date
AU731770B2 (en) 2001-04-05
NZ332323A (en) 1999-05-28
ATE215387T1 (de) 2002-04-15
DE69711609T2 (de) 2002-11-28
US6372510B1 (en) 2002-04-16
EP0888131B1 (de) 2002-04-03
AU2165797A (en) 1997-10-10
WO1997034642A1 (fr) 1997-09-25
EP0888131A1 (de) 1999-01-07

Similar Documents

Publication Publication Date Title
DE69609868T2 (de) Neue steroidester zur behandlung von hauterkrankungen
FR2824568B1 (fr) Procede de preparation de concentres d'immunoglobulines humaines a usage therapeutique
DE69019074D1 (de) Verfahren zur Fraktionierung von Plasmaproteinen.
SV1998000050A (es) Metodos mejorados para procesar proteina c actividad
DE3888205T2 (de) Verfahren zur behandlung von lungenaffektionen und zubereitungen dafür.
DE69624116T2 (de) Verfahren zur behandlung von allergischem asthma
DE69626976D1 (de) BEHANDLUNG EINER PROTEINLÖSUNG MIT A1/Fe UND ANSCHLIESENDE MEMBRANKONZENTRATION
DE69005959D1 (de) Verfahren zur Reinigung von menschlichem Serum-Albumin.
DE69613446T2 (de) Verfahren zur Behandlung von wässerigem Strom
DE69129115T2 (de) Neues verfahren zur behandlung von depression
DE69534701D1 (de) Verfahren zur behandlung von entzündlichen gelenkerkrankungen
SE8302483D0 (sv) Forfarande vid rening av biologiskt aktiva substanser
DE69702997D1 (de) Verfahren zur Behandlung von verunreinigtem Aluminiumoxid
DE69623191T2 (de) Verfahren zur Konzentration von saurem Phospholipid
DE69936994D1 (de) Verfahren zur behandlung von okularen neovaskularen erkrankungen
DE69711609T2 (de) Verfahren zum entfernen von unkonventionellen krankheitserregern aus proteinlösungen
DE69500167T2 (de) Wässrige Lösung zur Oberflächenbehandlung von Metallen
DE60144493D1 (de) Verfahren zur bestimmung und behandlung von tuberöse-sklerose komplex assoziierten erkrankungen
ATE211928T1 (de) Verfahren zur inaktivierung von viren in proteinen
DE68922409D1 (de) Verfahren zur gasartigen reinigung von halbleiterbauelementen.
DE3882411D1 (de) Verfahren zur trennung von aktiviertem menschlichem protein c.
ATE124706T1 (de) Verfahren zur isolierung von basalmembranproteinen aus menschlichen und tierischen geweben.
DE59008392D1 (de) Verfahren zur Abtrennung von Toxinen aus Proteinlösungen.
ATE71307T1 (de) Verfahren zur behandlung von kontaktlinsen.
DE69624430D1 (de) Verfahren und Vorrichtung zur selektiven Extraktion von Halogenionen aus photographischen Lösungen

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee